The authors wish to correct a mistake on the review “The role of drug transporters in the kidney: lessons from tenofovir” regarding the details of a particular ABCC2 polymorphism [−24C > T (rs717620)]. In the Section “Tenofovir and kidney transporter pharmacogenetics” on page five of the article, the second line on the second column should state the ABCC2 polymorphism as −24C > T, rather than −24T > C. Additionally, the sentence beginning on page five, line four of the second column should be changed from: “In a study in Japanese HIV+ patients, the ABCC2 −24C > T and1249G > A polymorphisms were found to be protective for tenofovir-induced kidney toxicity (Nishijima et al., 2012).” and instead read: “In a study in Japanese HIV+ patients, the ABCC2 −24T > C and 1249G > A polymorphisms were found to be associated with the increased occurrence of tenofovir-induced kidney toxicity (Nishijima et al., 2012).”
Statements
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
NishijimaT.KomatsuH.HigasaK.TakanoM.TsuchiyaK.HayashidaT.et al. (2012). Single nucleotide polymorphisms in ABCC2 associate with tenofovirinduced kidney tubular dysfunction in Japanese patients with HIV-1 infection: a pharmacogenetic study. Clin. Infect. Dis. 55, 1558–1567. 10.1093/cid/cis772
Summary
Keywords
tenofovir, HIV-1, drug transporters, kidney, toxicity
Citation
Moss DM (2015) Corrigendum: The role of drug transporters in the kidney: lessons from tenofovir. Front. Pharmacol. 6:18. doi: 10.3389/fphar.2015.00018
Received
22 December 2014
Accepted
20 January 2015
Published
09 February 2015
Volume
6 - 2015
Edited by
George Tegos, Massachusetts General Hospital, USA
Reviewed by
Olaf Grisk, University of Greifswald, Germany
Copyright
© 2015 Moss.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: darren.moss@liverpool.ac.uk
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.